✦ LIBER ✦

PCNI6 COMPARATIVE COSTS OF GEMCITABINE/CISPLATIN, PACLITAXEL/CARBOPLATIN AND VINORELBINE/CISPLATIN IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN GERMANY

✍ Scribed by H Bischoff; M Hamann; G Stynes; S Bhalla; D Tilden; A Kielhorn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-minimisation analysis comparing gem

✍ Novello, S.; Kielhorn, A.; Stynes, G.; Selvaggi, G.; De Marinis, F.; Maestri, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Pharmacoeconomic analysis of advanced no

✍ C. Rubio-Terrés; J.L. Tisaire; S. Kobina; A. Moyano 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

PCNI3 COST-EFFECTIVENESS ANALYSIS OF ADV

✍ A Skowron; J Brandys 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Randomized multicentric phase II study o

✍ Thomas, P.; Robinet, G.; Gouva, S.; Fournel, P.; Léna, H.; Le Caer, H.; Perol, M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Sequential chemotherapy of cisplatin and

✍ Dongiovanni, Diego; Fissore, Camilla; Berruti, Alfredo; Buffoni, Lucio; Addeo, A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 99 KB